Supplementary Figure 3 from Integrin Α6high Cell Population Functions As an Initiator in Tumorigenesis and Relapse of Human Liposarcoma

Lu Wang,Lingxian Wang,Ying Gu,Yongqian Shu,Yan Shen,Qian Xu

DOI: https://doi.org/10.1158/1535-7163.22496898.v1

2023-01-01

Abstract:PDF file - 46K, Knocking down the expression of CD13 leads to apoptosis in multiple cancer cells lines.

What problem does this paper attempt to address?

Supplementary Figure 2 from Integrin Α6high Cell Population Functions As an Initiator in Tumorigenesis and Relapse of Human Liposarcoma

Lu Wang,Lingxian Wang,Ying Gu,Yongqian Shu,Yan Shen,Qian Xu

DOI: https://doi.org/10.1158/1535-7163.22496901.v1

2023-01-01

Abstract:PDF file - 64K, Integrin a6 and CD13 co-express in multiple malignant cancer cell lines.
Supplementary Figure 1 from Integrin Α6high Cell Population Functions As an Initiator in Tumorigenesis and Relapse of Human Liposarcoma

Lu Wang,Lingxian Wang,Ying Gu,Yongqian Shu,Yan Shen,Qian Xu

DOI: https://doi.org/10.1158/1535-7163.22496904.v1

2023-01-01

Abstract:PDF file - 107K, Integrin a6-and CD13-double positive rate in multiple cancer cell lines.
Data from Integrin α6high Cell Population Functions as an Initiator in Tumorigenesis and Relapse of Human Liposarcoma

Lu Wang,Lingxian Wang,Yanhong Gu,Yongqian Shu,Yan Shen,Qiang Xu

DOI: https://doi.org/10.1158/1535-7163.c.6535425.v1

2023-01-01

Abstract:AbstractThe relapse and resistance to chemo- and radiotherapy are main problems in the treatment of human liposarcoma. It is important to find a functional marker existing in the liposarcoma cells for targeting. In this article, we established a new sub-cell line SW872-S cells with high tumorigenicity from human liposarcoma SW872 cells by repeated inoculation approach. The characteristic of the sub-cell line is linked to the high levels of integrin α6 on the surface. The integrin α6high cells show much higher tumor initiation and self-renewal potential in vivo than integrin α6low cells do. Targeting integrin α6 with its specific short interfering RNA and antibody significantly inhibits the cell adhesion to laminin and the tumor growth in vitro and in vivo, respectively. Interestingly, integrin α6 marks almost all of the surgical biopsy specimens of patients with liposarcoma relapse. Moreover, integrin α6 is found to coexpress with CD13, which might contribute to the antiapoptosis ability of integrin α6high cells. Consistently, integrin α6high cells are more sensitive to the CD13 inhibitor bestatin, and 61% of 23 other human tumor cell lines also contain integrin α6high CD13high subgroup. These results provide evidence, for the first time, to our knowledge, that integrin α6 and CD13 can serve as functional markers of the tumor-initiation subcell population in human liposarcoma as well as other cancers for therapeutic targeting. Mol Cancer Ther; 10(12); 2276–86. ©2011 AACR.
Supplementary Figure Legends and Supplementary Figures 1 Through 4 from A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Xiaohui Fan,Randall J. Brezski,Hui Deng,Pooja Dhupkar,Yun Q. Shi,Anneliese Gonzalez,Songlin Zhang,Michael A. Rycyzyn,William R. Strohl,Robert E. Jordan,Ningyan Zhang,Zhiqiang An

DOI: https://doi.org/10.1158/1535-7163.22501711

2023-01-01

Abstract:Figure S1: IdeS expression in BT474 breast cancer cells Figure S2: Detection of MMPs in cancer cell lysates and culture supernatant Figure S3: scIgG-T was not in the SKBR-3 cell culture medium Figure S4: Detection of immune cells infiltration in mice by flow cytometry.
Integrin Alpha 6(High) Cell Population Functions As An Initiator In Tumorigenesis And Relapse Of Human Liposarcoma

Lu Wang,Lingxian Wang,Yanhong Gu,Yongqian Shu,Yan Shen,Qiang Xu

DOI: https://doi.org/10.1158/1535-7163.MCT-11-0487

2011-01-01

Molecular Cancer Therapeutics

Abstract:The relapse and resistance to chemo- and radiotherapy are main problems in the treatment of human liposarcoma. It is important to find a functional marker existing in the liposarcoma cells for targeting. In this article, we established a new sub-cell line SW872-S cells with high tumorigenicity from human liposarcoma SW872 cells by repeated inoculation approach. The characteristic of the sub-cell line is linked to the high levels of integrin alpha 6 on the surface. The integrin alpha 6(high) cells show much higher tumor initiation and self-renewal potential in vivo than integrin alpha 6(low) cells do. Targeting integrin alpha 6 with its specific short interfering RNA and antibody significantly inhibits the cell adhesion to laminin and the tumor growth in vitro and in vivo, respectively. Interestingly, integrin alpha 6 marks almost all of the surgical biopsy specimens of patients with liposarcoma relapse. Moreover, integrin alpha 6 is found to coexpress with CD13, which might contribute to the antiapoptosis ability of integrin alpha 6(high) cells. Consistently, integrin alpha 6(high) cells are more sensitive to the CD13 inhibitor bestatin, and 61% of 23 other human tumor cell lines also contain integrin alpha 6(high) CD13(high) subgroup. These results provide evidence, for the first time, to our knowledge, that integrin alpha 6 and CD13 can serve as functional markers of the tumor-initiation subcell population in human liposarcoma as well as other cancers for therapeutic targeting. Mol Cancer Ther; 10(12); 2276-86. (C)2011 AACR.
Supplementary Figures 1-6 from Pivotal Role of Reduced let-7g Expression in Breast Cancer Invasion and Metastasis

Pengxu Qian,Zehua Zuo,Zhengsheng Wu,Xianyi Meng,Gaopeng Li,Zhengzhou Wu,Weijie Zhang,Sheng Tan,Vijay Pandey,Yandan Yao,Puyue Wang,Liqing Zhao,Jun Wang,Qiang Wu,Erwei Song,Peter E. Lobie,Zhinan Yin,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.22391051

2023-01-01

Abstract:PDF file - 2.16MB
Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced let-7g Expression in Breast Cancer Invasion and Metastasis

Pengxu Qian,Zehua Zuo,Zhengsheng Wu,Xianyi Meng,Gaopeng Li,Zhengzhou Wu,Weijie Zhang,Sheng Tan,Vijay Pandey,Yandan Yao,Puyue Wang,Liqing Zhao,Jun Wang,Qiang Wu,Erwei Song,Peter E. Lobie,Zhinan Yin,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.22391054

2023-01-01

Abstract:PDF file - 214K
Supplementary Figure 6 from the Pivotal Role of Integrin Β1 in Metastasis of Head and Neck Squamous Cell Carcinoma

Dongsheng Wang,Susan Müller,A.R.M. Ruhul Amin,Donghai Huang,Ling Su,Zhongliang Hu,Mohammad Aminur Rahman,Sreenivas Nannapaneni,Lydia Koenig,Zhengjia Chen,Mourad Tighiouart,Dong M. Shin,Zhuo G. Chen

DOI: https://doi.org/10.1158/1078-0432.22447170.v1

2023-01-01

Abstract:PDF file, 26K, Integrin β1 knock-down did not affected cell proliferation.
Figure S3 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419843.v1

2023-01-01

Abstract:Supplementary figure S3. Flow cytometry analyses of tumor draining lymph nodes.
Supplementary Figure 2 from LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses

Feng Xu,Jing Liu,Di Liu,Biao Liu,Min Wang,Zhiyuan Hu,Xuemei Du,Li Tang,Fuchu He

DOI: https://doi.org/10.1158/0008-5472.22399947.v1

2023-01-01

Abstract:PDF file - 31KB, Supplementary Figure 2 Determination of concentration of IL-6 and IL-10 within tumor.
Supplementary Figure 5 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401678

2023-01-01

Abstract:PDF file - 570K, LCN2 promotes lung metastasis in balb/c nude mice.
Supplementary Figure 2 from the Pivotal Role of Integrin Β1 in Metastasis of Head and Neck Squamous Cell Carcinoma

Dongsheng Wang,Susan Müller,A.R.M. Ruhul Amin,Donghai Huang,Ling Su,Zhongliang Hu,Mohammad Aminur Rahman,Sreenivas Nannapaneni,Lydia Koenig,Zhengjia Chen,Mourad Tighiouart,Dong M. Shin,Zhuo G. Chen

DOI: https://doi.org/10.1158/1078-0432.22447182

2023-01-01

Abstract:PDF file, 359K, OS and DFS analysis of chemotherapy on all patients.
Supplementary Figure 3 from Endogenous Interleukin-4 Promotes Tumor Development by Increasing Tumor Cell Resistance to Apoptosis

Zhiguang Li,Jing Jiang,Zibing Wang,Jinhua Zhang,Mingjie Xiao,Chunhui Wang,Yu Lu,Zhihai Qin

DOI: https://doi.org/10.1158/0008-5472.22373513

2023-01-01

Abstract:Supplementary Figure 3 from Endogenous Interleukin-4 Promotes Tumor Development by Increasing Tumor Cell Resistance to Apoptosis
Supplementary Figure 1 from FAK Inhibition Disrupts a Β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth

Isabelle Tancioni,Sean Uryu,Florian J. Sulzmaier,Nina R. Shah,Christine Lawson,Nichol Miller,Christine Jean,Xiao Lei Chen,Kristy Ward,David D. Schlaepfer

DOI: https://doi.org/10.1158/1535-7163.22501093.v1

2023-01-01

Abstract:PDF file - 894K, FAK and pY397 FAK immunostaining of human tissue array.
Supplementary Figure 2 from Endogenous Interleukin-4 Promotes Tumor Development by Increasing Tumor Cell Resistance to Apoptosis

Zhiguang Li,Jing Jiang,Zibing Wang,Jinhua Zhang,Mingjie Xiao,Chunhui Wang,Yu Lu,Zhihai Qin

DOI: https://doi.org/10.1158/0008-5472.22373516

2023-01-01

Abstract:Supplementary Figure 2 from Endogenous Interleukin-4 Promotes Tumor Development by Increasing Tumor Cell Resistance to Apoptosis
Supplementary Figure 1 from Endogenous Interleukin-4 Promotes Tumor Development by Increasing Tumor Cell Resistance to Apoptosis

Zhiguang Li,Jing Jiang,Zibing Wang,Jinhua Zhang,Mingjie Xiao,Chunhui Wang,Yu Lu,Zhihai Qin

DOI: https://doi.org/10.1158/0008-5472.22373519

2023-01-01

Abstract:Supplementary Figure 1 from Endogenous Interleukin-4 Promotes Tumor Development by Increasing Tumor Cell Resistance to Apoptosis
Supplementary Figures 5 - 6 from HAb18G/CD147 Promotes Pstat3-Mediated Pancreatic Cancer Development Via CD44s

Ling Li,Wenhua Tang,Xiaoqing Wu,David Karnak,Xiaojie Meng,Rachel Thompson,Xinbao Hao,Yongmin Li,Xiaotan T. Qiao,Jiayuh Lin,James Fuchs,Diane M. Simeone,Zhi-Nan Chen,Theodore S. Lawrence,Liang Xu

DOI: https://doi.org/10.1158/1078-0432.22446371.v1

2023-01-01

Abstract:PDF file - 451K, Figure S5: CyPA promotes HAb18G/CD147-CD44s-pSTAT3 signaling and correlated pancreatic cell growth (related to Figure 2, 3). Figure S6: HAb18G/CD147 and CD44s are co-expressed and associated in pancreatic cancer (related to Figure 4).
Supplementary Figure 4 from HAb18G/CD147 Promotes Pstat3-Mediated Pancreatic Cancer Development Via CD44s

Ling Li,Wenhua Tang,Xiaoqing Wu,David Karnak,Xiaojie Meng,Rachel Thompson,Xinbao Hao,Yongmin Li,Xiaotan T. Qiao,Jiayuh Lin,James Fuchs,Diane M. Simeone,Zhi-Nan Chen,Theodore S. Lawrence,Liang Xu

DOI: https://doi.org/10.1158/1078-0432.22446374

2023-01-01

Abstract:PDF file - 263K, The effects of HAb18G/CD147 promoting pancreatic tumor development are confirmed with pGIPZ and pTRIPZ CD147 shRNA (related to Figure 1).
Supplementary Figure 7 from LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses

Feng Xing,Jing Liu,Di Liu,Biao Liu,Min Wang,Zhiyuan Hu,Xiaoze Du,Tang Li,Fuchu He

DOI: https://doi.org/10.1158/0008-5472.22399932.v1

2023-01-01

Abstract:PDF file - 78KB, Supplementary Figure 7 Confirmation of LAG-3 expression on T cells.
Supplementary Figure 6 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401675

2023-01-01

Abstract:PDF file - 142K, The AKT signaling pathway is partly inactivated after NGALR knockdown.

Supplementary Figure 3 from Integrin Α6<sup>high</sup> Cell Population Functions As an Initiator in Tumorigenesis and Relapse of Human Liposarcoma

Supplementary Figure 2 from Integrin Α6<sup>high</sup> Cell Population Functions As an Initiator in Tumorigenesis and Relapse of Human Liposarcoma

Supplementary Figure 1 from Integrin Α6<sup>high</sup> Cell Population Functions As an Initiator in Tumorigenesis and Relapse of Human Liposarcoma

Data from Integrin α6<sup>high</sup> Cell Population Functions as an Initiator in Tumorigenesis and Relapse of Human Liposarcoma

Supplementary Figure Legends and Supplementary Figures 1 Through 4 from A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Integrin Alpha 6(High) Cell Population Functions As An Initiator In Tumorigenesis And Relapse Of Human Liposarcoma

Supplementary Figures 1-6 from Pivotal Role of Reduced <i>let-7g</i> Expression in Breast Cancer Invasion and Metastasis

Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced <i>let-7g</i> Expression in Breast Cancer Invasion and Metastasis

Supplementary Figure 6 from the Pivotal Role of Integrin Β1 in Metastasis of Head and Neck Squamous Cell Carcinoma

Figure S3 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Supplementary Figure 2 from LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses

Supplementary Figure 5 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 2 from the Pivotal Role of Integrin Β1 in Metastasis of Head and Neck Squamous Cell Carcinoma

Supplementary Figure 3 from Endogenous Interleukin-4 Promotes Tumor Development by Increasing Tumor Cell Resistance to Apoptosis

Supplementary Figure 1 from FAK Inhibition Disrupts a Β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth

Supplementary Figure 2 from Endogenous Interleukin-4 Promotes Tumor Development by Increasing Tumor Cell Resistance to Apoptosis

Supplementary Figure 1 from Endogenous Interleukin-4 Promotes Tumor Development by Increasing Tumor Cell Resistance to Apoptosis

Supplementary Figures 5 - 6 from HAb18G/CD147 Promotes Pstat3-Mediated Pancreatic Cancer Development Via CD44s

Supplementary Figure 4 from HAb18G/CD147 Promotes Pstat3-Mediated Pancreatic Cancer Development Via CD44s

Supplementary Figure 7 from LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses

Supplementary Figure 6 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 3 from Integrin Α6&lt;sup&gt;high&lt;/sup&gt; Cell Population Functions As an Initiator in Tumorigenesis and Relapse of Human Liposarcoma

Supplementary Figure 2 from Integrin Α6&lt;sup&gt;high&lt;/sup&gt; Cell Population Functions As an Initiator in Tumorigenesis and Relapse of Human Liposarcoma

Supplementary Figure 1 from Integrin Α6&lt;sup&gt;high&lt;/sup&gt; Cell Population Functions As an Initiator in Tumorigenesis and Relapse of Human Liposarcoma